Your Expertise Please BNC vs. OGXIHi
Some great opionions on this board, but can someone please tell me why we are trading at only 80 cents and change when OGXI (NASDAG) oncogenex is trading at $14.51 per share and they are just entering their 3rd stage trial???
I have placed below a excerpt from one of their releases. Seems like BNC is so much farther ahead, yet their share price for OGXI is worth 20 x more?
- Recent and upcoming data presentations at scientific meetings such as the American Association of Cancer Research, the Society of Urologic Oncology and the American Urological Association, provide new pre-clinical evidence and enhance the understanding of OncoGenex' product candidates, custirsen and OGX-427.
- Two additional trials scheduled to commence this year; a Phase 3 clinical trial to evaluate a survival benefit for custirsen in combination with first-line chemotherapy in patients with non-small cell lung cancer (NSCLC) and a Phase 2 clinical trial of OGX-427 in approximately 180 patients with metastatic bladder cancer.
"We recognize the prostate cancer landscape is evolving rapidly and the approval of new treatments is encouraging news for patients," said Scott Cormack, president and CEO of OncoGenex. "The proposed revision to the SATURN trial will help ensure custirsen remains aligned with currently approved chemotherapy."
Your explanations and opinions are valued.
Thanks and good luck